Anita Clayton, MD; John J. Miller, MD; Sanjai Rao, MD, DFAPA; Larry Culpepper, MD; Corine de Boer, MD, PhD; Rif S. El-Mallakh, MD; C. Neill Epperson, MD; Marlene P. Freeman, MD; Nassir Ghaemi, MD, MPH; Joseph F. Goldberg, MD; Benjamin D. Greenberg, MD, PhD; Mark B. Hamner, MD; Brian Hurley, MD, MBA, DFASAM; Alana Iglewicz, MD; Jonathan M. Meyer, MD; Nidal Moukaddam, MD, PhD; Sonya Norman, PhD; Edward Nunes, MD; Dhakshin Ramanathan, MD, PhD; Christopher Schneck, MD; M. Katherine Shear, MD; Michael E. Thase, MD; J. Eric Vance, MD; David B. Yaden, PhD; Rachel Yehuda, PhD; Sidney Zisook, MD

2022 Annual Psychiatric Times™ World CME Conference™ - Day Two

Expert Illustrations & Commentaries™: Exploring the Clinical Rationale for Antagonizing Inflammatory IL-1-beta Signaling in NSCLC

2022 Annual Psychiatric Times™ World CME Conference™ - Day One

2022 Annual Psychiatric Times™ World CME Conference™ - Day Three

Abbey Kaler, MS, APRN, FNP-C; Kelly Leonard, MSN, APRN, FNP-BC

Cases and Conversations™: Nursing Considerations for the Management of ER+ Breast Cancer

Colleen Cotton, MD, FAAD; Raj Chovatiya, MD, PhD, FAAD

Advances in™ Hidradenitis Suppurativa (HS): Optimizing the Management Approach with Available and Emerging Treatments

Robert Z. Orlowski, MD, PhD; Elisabet E. Manasanch, MD, MHSc; Jing Christine Ye, MD, MSc

Charting The Changing Landscape in Multiple Myeloma from Frontline to Relapsed/Refractory Disease

Neil M. Bressler, MD; Jennifer I. Lim, MD, FARVO

(COPE Credit) Community Practice Connections™: Comprehensive Key Advances in Biosimilars for Retinal Diseases – Reviewing the Evidence, Addressing Patient Perspectives, and Practice Utilization for the Retina Specialist

(CME/CNE Credit) Community Practice Connections™: Comprehensive Key Advances in Biosimilars for Retinal Diseases – Reviewing the Evidence, Addressing Patient Perspectives, and Practice Utilization for the Retina Specialist

Jennifer Dvorak, MSN, FNP-BC; Beth Sandy, MSN, CRNP

Onco-Nurse Academy™: Exploring an Advent of Targeted Therapies Across Advanced NSCLC Care and Strategies for Managing Adverse Events Associated With Treatment

Neal Shore, MD, FACS; Scott Tagawa, MD, MS, FACP

Expert Illustrations & Commentaries™: The Role of Radioligand Therapy in mCRPC and How It Could Impact Your Practice in the Future

Arshad M. Khanani MD, MA; Jennifer I. Lim MD, FARVO, FASRS

(COPE Credit) Expert Illustrations & Commentaries™: Visualizing the Angiopoetin-Tie2 Pathway as a Target in Retinal and Choroidal Vascular Diseases

(CME/CNE Credit) Expert Illustrations & Commentaries™: Visualizing the Angiopoetin-Tie2 Pathway as a Target in Retinal and Choroidal Vascular Diseases

Expert Illustrations & Commentaries™: Targeting FGFR2b Overexpression in Advanced Gastric and GEJ Cancers

Elias Jabbour, MD; Hagop M. Kantarjian, MD

Community Practice Connections™: Translating Recent Evidence to the Real-World Management of Acute Lymphoblastic Leukemia

Joyce O’Shaughnessy, MD; Balazs Halmos, MD, MS; Cathy Eng, MD, FACP, FASCO;  Brian I. Rini, MD, FASCO; Saad Z. Usmani, MD, MBA, FACP; Nilanjan Ghosh, MD, PhD

  Community Practice Connections™: ASCO Direct Highlights: Practice-Changing Data From the Leading Oncology Conference

Jason J. Luke, MD, FACP; Evan J. Lipson, MD; Yana G. Najjar, MD; Daniel Olson, MD; Sapna Patel, BA, MD

  Medical Crossfire ®: Addressing the Top 10 Clinical Challenges in Melanoma

Pasi A. Jänne, MD, PhD; Jason Chang, MD; Gregory Riely, MD, PhD; Beth Sandy, MSN, CRNP, OCN 

Clinical Vignettes®: Multidisciplinary Discussions on the Application of Novel EGFR Exon 20 Targeted Regimens for NSCLC Management

Ticiana A. Leal, MD; Jordyn P. Higgins, PharmD, BCOP; Ashley Rollins, BSN, OCN

Patient, Provider, and Caregiver Connection™: Shedding a Light on the Patient Journey with KRAS Mutated Lung Cancer

Balazs Halmos, MD, MS; Lynette M. Sholl, MD; Matthew Galsky, MD, FASCO; Kevin Kalinsky, MD, MS; Samuel J. Klempner, MD

Community Practice Connections™: 6th Annual International Congress on Oncology & Pathology™: Towards Harmonization of Pathology and Oncology Standards

Arshad M. Khanani, MD, MA; Peter K. Kaiser, MD; Anat Loewenstein, MD, MHA; Christina Y. Weng, MD, MBA, FASRS

Cases & Conversations™: Inflammation & Pathogenesis in DME – Rethinking the Traditional Treatment Paradigm

Neil M. Bressler, MD; Sophie J. Bakri, MD, MBA; Jennifer I. Lim, MD, FARVO

Comprehensive Key Advances in Biosimilars for Retinal Diseases – Reviewing the Evidence, Addressing Patient Perspectives, and Practice Utilization for the Retina Specialist

Naval G. Daver, MD ; Guillermo Garcia-Manero, MD ; Uma Borate, MD, MS ; Jacqueline S. Garcia, MD 

Clinical Vignettes: Reshaping Higher-Risk MDS Patient-Centered Care with Emergence of Novel Evidence and Clinical Trials

Mile Brujic, OD, FAAO; Marc R. Bloomenstein, OD, FAAO; Selina McGee, OD, FAAO

(COPE Credit) Community Practice Connections™: Understanding Emerging Options in MGD-Associated Dry Eye Disease—Preparing for an Updated Armamentarium

(CME Credit) Community Practice Connections™: Understanding Emerging Options in MGD-Associated Dry Eye Disease—Preparing for an Updated Armamentarium

Expert Illustrations & Commentaries™: Exploring the Role of Novel Antibody-Drug Conjugates in Advanced NSCLC

BURST Expert Illustrations & Commentaries™: Personalizing Treatment Regimens for Patients with Hemophilia

Laura S. Wood RN, MSN, OCN; Kathleen D. Burns, MSN, AGACNP-BC, OCN; Michael E Seabright Jr, PharmD, BCOP

Show Me Your Care Plan! Developing Multidisciplinary Strategies to Optimize the First-Line Care of Patients with mRCC

Bradley J. Monk, MD, FACS, FACOG; Bhavana Pothuri, MD, MS; Matthew A. Powell, MD

Community Practice Connections®: How Are We Personalizing Integration of ICIs and Targeted Therapies to Optimize Outcomes in Endometrial Cancer?

Elizabeth (Ebbie) Stewart, MD; Hugh Taylor, MD; Homa K. Ahmadzia, MD, MPH; Alyssa Brown, MD; Isabel C. Green, MD; Cynthia Gyamfi-Bannerman, MD, MS; Michael J. Joyner, MD; Amanda N. Kallen, MD, FACOG; Beth Y. Karlan, MD; Heather S. Lipkind, MD, MS; Judette Louis, MD, MPH; JoAnn V. Pinkerton, MD, FACOG, NCMP; Nancy Ringel, MD, MS; Nanette Santoro, MD; Moeun Son, MD, MSCI, FACOG

3rd Annual International Congress on the Future of Women’s Health™

Broadening the Impact of Adjuvant Immunotherapy in Melanoma 

Ophthalmology Consultations™: Keeping an Eye Out for MGD-Associated Dry Eye in Pre/Post-Op Patients – Improving Surgical Outcomes by Optimizing the Surface

Arshad M. Khanani, MD, MA; Anat Loewenstein, MD, MHA

Community Practice Connections™: Inflammation & Pathogenesis in DME – Rethinking the Traditional Treatment Paradigm

Hanny Al-Samkari, MD; Kevin H.M. Kuo, MD, MSc, FRCPC; Sujit Sheth, MD

Medical Crossfire®: Strategies to Manage Transfusional Iron Overload in Patients with ß-hemoglobinopathies: Optimizing Patient Outcomes

Edgardo S. Santos, MD, FACP; Julia Rotow, MD

Advances In™ NSCLC: Exploring CEACAM5 As A New Therapeutic Target

Kenneth C. Anderson, MD; Elias Jabbour, MD; Gilles A. Salles, MD, PhD

Community Practice Connections™: 6th Annual Live Medical Crossfire®: Hematologic Malignancies 

Daniel C. Brennan, MD, FACP; Stanley C. Jordan, MD; Yousuf Kyeso, MD; Bonnie Lonze, MD, PhD

Community Practice Connections™: Expert Approaches to Preventing Graft Failure in Renal Transplant Recipients 

Megan Hinkley, PharmD, BCOP; Meg Taylor, PharmD, CPP

Updates in Therapeutic Strategies for Metastatic Renal Cell Carcinoma: A Multidisciplinary Approach to Optimal Management of Adverse Effects, featuring Counseling Vignettes

Emanuele Zucca, MD; Massimo Federico, MD; Pier Luigi Zinzani, MD, PhD 

Medical Crossfire®: How the Experts Manage Advanced HL and PTCL in the Real World from Frontline to R/R Treatment Settings

Brett King, MD, PhD; Brittany Craiglow, MD

An Animated View of Alopecia Areata to Advance Our Approaches to Patient Management

Cancer Summaries and Commentaries™: Investigating Key Updates for the Treatment and Management of AML and MDS

Follicular Lymphoma Workshop: Forging Patient-Centric Plans With Targeted Therapies Across Lines of Care

22nd Annual International Congress on the Future of Breast Cancer® West

Reflective Case-Based Oncology Collective™: Strategic Algorithms for Challenging Cases in Relapsed/Refractory Multiple Myeloma

Charu Aggarwal, MD, MPH; Dara Aisner, MD, PhD; Balazs Halmos, MD, MS; Julia Kathleen Rotow, MD; David R. Gandara, MD

Community Practice Connections™: Top 10 Oncogenic Markers in NSCLC for 2022: Evolution of Tumor Testing Technologies, Novel Treatments, and Trials!

Scott Tagawa, MD, MS, FACP; Alicia Morgans, MD, MPH; Michael J. Morris, MD

Medical Crossfire®: Key Questions on Sequencing, Radioligands, and Novel Emerging Approaches in CRPC

Sara A. Hurvitz, MD, FACP; Aditya Bardia, MD, MPH

Community Practice Connections™: Incorporating Novel HER2-Targeted Therapies Into Treatment Algorithms Across Metastatic Breast Cancer

Robert L. Coleman, MD, FACOG, FACS; Ursula A. Matulonis, MD; Bradley J. Monk, MD, FACS, FACOG; Kathleen Moore, MD

Community Practice Connections™: 13th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™

Narjust Duma, MD; Coral Olazagasti, MD; Gilberto de Lima Lopes, MD, MBA, FASCO; Ana Maria López, MD, MPH, MACP, FRCP;  Vonetta M. Williams, MD, PhD

Working Group™: Strategies for Recognizing and Taking Steps to Address Disparities in Cancer Care Among Diverse Populations

Jessica Michaud Davis, PharmD, BCOP, CPP; Robert L. Ferris, MD, PhD; Kristi K Orbaugh, MSN, NP, AOCNP

Optimizing Immune Checkpoint Inhibitors in Early-Stage Cancer Treatment Through Multidisciplinary Collaboration

Benjamin P. Levy, MD; David R. Gandara, MD; Aparna R. Parikh, MD, MS; Heather A. Parsons, MD, MPH

Community Practice Connections™:  Analyzing the Evolving Role of Liquid Biopsies Across Cancer Care

Reflective Case-Based Oncology Collective™: Translating Recent Evidence to the Real-World Management of Acute Lymphoblastic Leukemia

24th Annual International Lung Cancer Congress®

Clinical Vignettes™: Testing and Treatment Strategies in Cholangiocarcinoma

2nd Annual Virtual Tumor Board®: Integrating Emerging Testing Methodologies into Optimal Treatment Planning in GI Cancers

James L.M. Ferrara, MD, DSc; Carrie L. Kitko, MD

Community Practice Connections™: Incorporating Novel Therapies Into Treatment Algorithms Across Acute and Chronic GVHD

Advanced Renal Cell Carcinoma: Tyrosine Kinase Inhibitors Versus Immune Checkpoint Inhibitors

Sandra Kurtin, PhD, ANP-BC, AOCN; Ravi Vij, MD, MBA; Kathryn Maples, PharmD, BCOP

Advances In: Interprofessional Strategies to Optimize Outcomes for Patients with Relapsed/Refractory Multiple Myeloma: Expert Discussions to Maximize Safety and Efficacy

Virtual Testing Board: Digging Deeper on Your Testing Reports to Elevate Patient Outcomes in Advanced Non–Small Cell Lung Cancer

Clement L. Ren, MD, MBA, ATSF; Samya Nasr, MD, CPI, ATSF; George M. Solomon, MD

Clinical Consultations™: Optimizing Treatment Outcomes for Patients With Cystic Fibrosis

BURST CME™: Exploring the Biologic Rationale for Novel IRAK4-directed Therapy for the Treatment of High Risk MDS and AML 

Bradley J. Monk, MD, FACS, FACOG; Lucy Gilbert, MD, MSc, FRCOG; Bhavana Pothuri, MD, MS; Matthew A. Powell, MD

Medical Crossfire®: How Are We Personalizing Integration of ICIs and Targeted Therapies to Optimize Outcomes in Endometrial Cancer?

4th Annual Virtual Tumor Board®: Diagnosis and Management of Polycythemia Vera and Myelofibrosis

Jeff Unger, MD, FAAFP, FACE;  Jennifer D. Goldman, PharmD, RPh, CDCES, BC-ADM, FCCP; Carrie McAdam-Marx, PhD, RPh; Brittany Hoffmann-Eubanks, PharmD, MBA; Angel A. Rodriguez, PharmD; Lori A. Uildriks, PharmD, BCPS, BCGP; Jeannette Y. Wick, RPh, MBA, FASCP

Analyzing the Value of Continuous Glucose Monitoring in Diabetes Care and Overcoming Barriers Through Expanded Pharmacy Access

Virtual Show Me the Data™: How HER2, HER3, and TROP2 Targeted Strategies Will Impact Evolving Paradigms in NSCLC

Caring for Patients on CAR T-Cell Therapy in the Inpatient Versus Outpatient Setting

Advances In™: The Role of NRG1 Fusions Across Tumor Types

Tiffany A. Traina, MD; Odessa Williams, AGPCNP-BC; Latasha Jordan; Nicole Badgett

Patient, Provider, and Caregiver Connection™: Addressing Patient Concerns During the Treatment and Management of TNBC

Terry P. Mamounas, MD, MPH, FACS; Joyce O’Shaughnessy, MD; David M. Euhus, MD, FACS

Community Practice Connections™: Navigating Adjuvant Decision-Making for High-Risk Early-Stage Hormone Receptor-Positive Breast Cancer

Christopher R. Flowers, MD, MS, FASCO; Frederick L. Locke, MD; Kami J. Maddocks, MD; Laurie H. Sehn MD, MPH

Hot Seat™: Expert Considerations to Maximize the Clinical Benefits of Targeted Therapies in Patients With Relapsed/Refractory DLBCL

Aditya Bardia, MD, MPH; Erika P. Hamilton, MD; Komal Jhaveri, MD, FACP; Nicholas Turner, MD, PhD 

  Medical Crossfire®: Evaluating the Potential Role of Next-Generation Selective Estrogen Receptor Degraders in the ER+/HER2- Breast Cancer Treatment Paradigm

Jonathan I. Silverberg, MD, PhD, MPH, FAAD; Peck Y. Ong, MD


Individualizing Treatment in Moderate-to-Severe Atopic Dermatitis through Improved Clinician-Patient Communication

Edward B. Garon, MD, MS; Lyudmila Bazhenova, MD; Solange Peters, MD, PhD; Zofia Piotrowska, MD, MHS

Medical Crossfire®: Leveraging EGFR Mutation Profiles to Personalize Therapeutic Decisions in Resected and Metastatic NSCLC Settings

Ruben A. Mesa, MD, FACP ; Jamile M. Shammo, MD, FASCP, FACP ; Naveen Pemmaraju, MD 

Expert Illustrations and Commentaries™: Placing New MPN Therapies Into Context Through Illustrated Case Discussions

Robert Dreicer, MD, MS, MACP, FASCO; Tomasz Beer, MD, FACP; Scott Tagawa, MD, MS, FACP; Tanya Dorff, MD

How Guidelines and Recent Clinical Trial Data Inform the Modern-Day Treatment of Advanced Prostate Cancer

Dawn A. Laney, MS, CGC; Eric Wallace, MD, FASN

Clinical ConsultationsTM: Focusing on Fabry Disease in Females: Individualizing Diagnostic and Counseling Plans to Improve Long-Term Outcomes

Wendy L. Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP; Leah Smith, MSN, APRN, FNP-BC, CNN-NP, FNKF; Catherine Wells, DNP, ACNP, CNN-NP, FNKF

Cases and Conversations: Individualizing Diabetes Care in the Management of Chronic Kidney Disease: Developing the Optimal Treatment Plan With Your Patient

John Rhodes, MD; Robert J. Sommer, MD; Christine A. Holmstedt, DO

Medical Crossfire: Optimizing Outcomes for Patients with Stroke: Secondary Prevention and Risk Reduction

Susanna V Ulahannan, MD, MMEd; Manish Patel, MD


Expert Illustrations & Commentaries™: The Role of B7-H3 Across Tumor Types and How It Could Impact Your Practice in the Future

Jeffrey Laurence, MD; Mitchell S. Cairo, MD; Vincent T. Ho, MD; Sonata Jodele, MD

New Perspectives in HSCT-TMA: Driving the Future of Diagnosis and Treatment

Luciano J. Costa, MD, PhD; Paul Shaughnessy, MD

Optimizing ASCT in Patients With Multiple Myeloma and Non-Hodgkin Lymphoma Through Stem Cell Mobilization Techniques

Anita Afzali, MD, MPH, MHCM; Marla C. Dubinsky, MD; Christina Ha, MD, FACG, AGAF

Optimizing Care in Inflammatory Bowel Disease (IBD): The Role of Emerging Therapies in Improving Patient Outcomes

Jane S. Davis, CRNP, DNP; Jean Colaneri, ACNP-BC, CNN-NP

Community Practice Connections™: Expert Illustrations and Commentaries: Nephrology Nurse Perspectives in Anemia in CKD

Genovefa Papanicolaou, MD; Guenther Koehne, MD, PhD; Roy F. Chemaly, MD, MPH, FIDSA, FACP; Sanjeet Dadwal, MD, FACP, FIDSA

Community Practice Connections™: Evolving Paradigms in Transplant-Related CMV Prevention and Management: Setting Foundations for Improved Patient Outcomes

CAR T-Cell Therapy in Multiple Myeloma: Key Considerations for Patient Selection, Transplant, and Applying Recent Data

Evolving Paradigms in Transplant-Related CMV Prevention and Management: Setting Foundations for Improved Patient Outcomes

Burst CME: Improving Outcomes for Your Patient with Vitiligo

Elizabeth Verna, MD, MSc; Arun B. Jesudian, MD

Clinical Consultations™: Facilitating Optimal Treatment Outcomes and Multidisciplinary Care in Hepatorenal Syndrome- Acute Kidney Injury (HRS-AKI)

Burst Expert Illustrations & Commentaries™: Management Strategies for Refractory Ascites

Elizabeth Verna, MD, MSc; Lisa B. VanWagner, MD, MSc, FAST, FAHA

Advances In™ Cirrhosis: Reframing the Management of Hepatorenal Syndrome-Acute Kidney Injury: A Review of Current Strategies

Burst Expert Illustrations & Commentaries™: Current Treatments for Esophageal Variceal Hemorrhage

The 14th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™

Matthew Lunning, DO, FACP; Yi Lin, MD, PhD

Community Practice Connections™: Translating Recent Evidence on CAR T-Cell Therapy to the Real-World Management of Lymphoid Malignancies

Corey S. Cutler, MD, MPH; Catherine Lee, MD

Expert Illustrations & Commentaries™: Exploring the Rationale for Emerging Mechanistic Approaches in cGvHD

Fátima Cardoso, MD; Mario Campone, MD, PhD; Giuseppe Viale, MD, FRCPath

Tumor Board: How The Experts Approach Personalized Care Plans in ER-Positive Breast Cancer

Charu Aggarwal, MD, MPH; Dara Aisner MD, PhD; D. Ross Camidge, MD, PhD; Balazs Halmos, MD, MS; Julia Kathleen Rotow, MD

Top 10 Oncogenic Markers in NSCLC for 2022: Evolution of Tumor Testing Technologies, Novel Treatments, and Trials!

Krishna Komanduri, MD; Juan Ramirez, APRN-BC; Charalambos Andreadis, MD; Laura J. Zitella, NP, MSN

Community Practice Connections™: Optimally and Safely Integrating Novel Therapies Across the DLBCL Care Spectrum

Moving Beyond Medications: Practices to Provide Appropriate Care for People Living With HIV

Back to Basics: Initiating and Monitoring HIV Treatment

1.5 Credits / HIV/AIDS, Infectious Disease

An Interprofessional Discussion on How to Overcome Barriers and Improve Access to HIV PrEP

Combatting the Monkeypox Outbreak: What Pharmacists Need to Know

1.5 Credits / Immunization, Infectious Disease, Respiratory

Vaccines to Reduce the Burden of Respiratory Syncytial Virus in Older Adults: Understanding the Importance and the Role of the Pharmacist

1.0 Credit / HIV/AIDS, Infectious Disease

Addressing the Barriers to Initiating HIV PrEP Through Managed Care Interventions (Pharmacy Technician Credit)

Addressing the Barriers to Initiating HIV PrEP Through Managed Care Interventions (Pharmacist Credit)

Recent Advancements in COVID-19 Vaccination: An Update for Pharmacists

The Challenges of Hospital-Acquired and Ventilator-Associated Pneumonia and Recent Advancements in Antibiotic Treatment

0.75 Credit / Infectious Disease, Respiratory, Rheumatology

Exploring the Results of Interleukin-6- Receptor Antagonists in Hospitalized Patients with Severe COVID-19 Infections

1.0 Credit / Immunization, Infectious Disease

The Expanding Landscape of Vaccinations for the Prevention of Pneumococcal Disease: The Role of the Pharmacist as Patient Educator and Vaccinator

Where Are We Now? The Changing Role of Pharmacists in the COVID-19 Treatment Landscape

1.5 Credit / Respiratory, Infectious Disease

Emerging Vaccines for Preventing and Reducing the Risks Associated with Respiratory Syncytial Virus (RSV) in Older Adults: Meeting an Urgent Need

1.5 Credit / Immunization, Infectious Disease

Preventing Pneumococcal Disease Through Vaccination and the Pharmacist’s Role

1 Credit / Christopher Bland; Infectious Disease; COVID-19; Vaccines

Continuing Education